Literature DB >> 9636618

Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.

S Walker1, S Habib, M Rose, M Yacoub, N Banner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636618     DOI: 10.1016/s0041-1345(98)00341-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.

Authors:  Katherine A Barraclough; Nicole M Isbel; Carl M Kirkpatrick; Katie J Lee; Paul J Taylor; David W Johnson; Scott B Campbell; Diana R Leary; Christine E Staatz
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

Review 2.  Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.

Authors:  Caroline Monchaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.

Authors:  Caroline Monchaud; Brenda C de Winter; Christiane Knoop; Marc Estenne; Martine Reynaud-Gaubert; Christophe Pison; Marc Stern; Romain Kessler; Romain Guillemain; Pierre Marquet; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2012-03-01       Impact factor: 6.447

6.  Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration.

Authors:  Gustavo Adolfo Centeno Soto; Belén Ruiz-Antorán; Rosalía Laporta; Arantxa Sancho; María Teresa Lázaro; Concepción Payares Herrera; Isabel Salcedo; Maria Angeles Cos; Ferrán Torres; Piedad Usetti; Cristina Avendaño-Sola
Journal:  Eur J Clin Pharmacol       Date:  2015-05-09       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.